{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:36:53Z","timestamp":1781195813661,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS109607"],"award-info":[{"award-number":["R01NS109607"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS121337"],"award-info":[{"award-number":["R01NS121337"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS064928"],"award-info":[{"award-number":["T32NS064928"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2021030S"],"award-info":[{"award-number":["A2021030S"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-17-533511-RAPID"],"award-info":[{"award-number":["AARF-17-533511-RAPID"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alzheimer\u2019s disease (AD) pathology includes transcriptional changes in the neurons, which are in part caused by the heterodimerization of two stress response transcription factors, CREB3L2 and ATF4. We investigated the role of proteasome inhibition and the eIF2\u03b1-kinase HRI in the formation of CREB3L2-ATF4 in neurons exposed to soluble oligomeric A\u03b2<jats:sub>42<\/jats:sub>. While HRI activation increased ATF4 expression, it decreased CREB3L2 and CREB3L2-ATF4 levels. Proteasome inhibition, induced by A\u03b2<jats:sub>42<\/jats:sub>, leads to increased levels of both transcription factors in the nucleus. These findings suggest that CREB3L2 levels are normally kept low due to rapid degradation, but proteasome inhibition in response to A\u03b2<jats:sub>42<\/jats:sub> disrupts this balance, increasing CREB3L2 and heterodimer levels. Activation of HRI not only reduced CREB3L2 and heterodimer levels but also prevented the transcriptional dysregulation of a CREB3L2-ATF4 target, SNX3. Our results suggest that manipulating the HRI pathway during proteasome inhibition could help restore normal gene expression in the context of AD-related protein accumulation.<\/jats:p>","DOI":"10.1038\/s41419-025-07586-0","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T07:24:42Z","timestamp":1743405882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer\u2019s disease pathology"],"prefix":"10.1038","volume":"16","author":[{"given":"Krystal","family":"Herline-Killian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela M.","family":"Pauers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Lipponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Zrzavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio","family":"Gouveia Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan P.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Min","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8061-2861","authenticated-orcid":false,"given":"Ulrich","family":"Hengst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"7586_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"7586_CR2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87:539\u201347.","journal-title":"Neurology"},{"key":"7586_CR3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1523\/JNEUROSCI.4098-07.2008","volume":"28","author":"JA Miller","year":"2008","unstructured":"Miller JA, Oldham MC, Geschwind DH. A systems level analysis of transcriptional changes in Alzheimer\u2019s disease and normal aging. J Neurosci. 2008;28:1410\u201320.","journal-title":"J Neurosci"},{"key":"7586_CR4","volume":"4","author":"C Gouveia Roque","year":"2024","unstructured":"Gouveia Roque C, Phatnani H, Hengst U. The broken Alzheimer\u2019s disease genome. Cell Genom. 2024;4:100555.","journal-title":"Cell Genom"},{"key":"7586_CR5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.cell.2014.07.001","volume":"158","author":"J Baleriola","year":"2014","unstructured":"Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, et al. Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell. 2014;158:1159\u201372.","journal-title":"Cell"},{"key":"7586_CR6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add2671","volume":"9","author":"C Gouveia Roque","year":"2023","unstructured":"Gouveia Roque C, Chung KM, McCurdy EP, Jagannathan R, Randolph LK, Herline-Killian K, et al. CREB3L2-ATF4 heterodimerization defines a transcriptional hub of Alzheimer\u2019s disease gene expression linked to neuropathology. Sci Adv. 2023;9:eadd2671.","journal-title":"Sci Adv"},{"key":"7586_CR7","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745435","volume":"19","author":"CA Walker","year":"2018","unstructured":"Walker CA, Randolph LK, Matute C, Alberdi E, Baleriola J, Hengst U. Abeta(1-42) triggers the generation of a retrograde signaling complex from sentinel mRNAs in axons. EMBO Rep. 2018;19:e45435.","journal-title":"EMBO Rep."},{"key":"7586_CR8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.20667","volume":"58","author":"SA Small","year":"2005","unstructured":"Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, et al. Model-guided microarray implicates the retromer complex in Alzheimer\u2019s disease. Ann Neurol. 2005;58:909\u201319.","journal-title":"Ann Neurol"},{"key":"7586_CR9","first-page":"4693","volume":"125","author":"MN Seaman","year":"2012","unstructured":"Seaman MN. The retromer complex - endosomal protein recycling and beyond. J Cell Sci. 2012;125:4693\u2013702.","journal-title":"J Cell Sci"},{"key":"7586_CR10","doi-asserted-by":"crossref","first-page":"33165","DOI":"10.1074\/jbc.M110.167213","volume":"285","author":"S Dey","year":"2010","unstructured":"Dey S, Baird TD, Zhou D, Palam LR, Spandau DF, Wek RC. Both transcriptional regulation and translational control of ATF4 are central to the integrated stress response. J Biol Chem. 2010;285:33165\u201374.","journal-title":"J Biol Chem"},{"key":"7586_CR11","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1128\/MCB.01552-06","volume":"27","author":"S Kondo","year":"2007","unstructured":"Kondo S, Saito A, Hino S, Murakami T, Ogata M, Kanemoto S, et al. BBF2H7, a novel transmembrane bZIP transcription factor, is a new type of endoplasmic reticulum stress transducer. Mol Cell Biol. 2007;27:1716\u201329.","journal-title":"Mol Cell Biol"},{"key":"7586_CR12","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","volume":"368","author":"M Costa-Mattioli","year":"2020","unstructured":"Costa-Mattioli M, Walter P. The integrated stress response: From mechanism to disease. Science. 2020;368:eaat5314.","journal-title":"Science"},{"key":"7586_CR13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/14728222.2017.1397133","volume":"21","author":"N Burwick","year":"2017","unstructured":"Burwick N, Aktas BH. The eIF2-alpha kinase HRI: a potential target beyond the red blood cell. Expert Opin Ther Targets. 2017;21:1171\u20137.","journal-title":"Expert Opin Ther Targets"},{"key":"7586_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/BJ20080324","volume":"412","author":"A Yerlikaya","year":"2008","unstructured":"Yerlikaya A, Kimball SR, Stanley BA. Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase. Biochem J. 2008;412:579\u201388.","journal-title":"Biochem J"},{"key":"7586_CR15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1134\/S0026893310050122","volume":"44","author":"A Yerlikaya","year":"2010","unstructured":"Yerlikaya A, DoKudur H. Investigation of the eIF2alpha phosphorylation mechanism in response to proteasome inhibition in melanoma and breast cancer cells. Mol Biol. 2010;44:859\u201366.","journal-title":"Mol Biol"},{"key":"7586_CR16","doi-asserted-by":"crossref","unstructured":"Alvarez-Castelao B, Tom Dieck S, Fusco CM, Donlin-Asp P, Perez JD, Schuman EM. The switch-like expression of heme-regulated kinase 1 mediates neuronal proteostasis following proteasome inhibition. Elife 9, (2020)","DOI":"10.7554\/eLife.52714"},{"key":"7586_CR17","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1038\/s41388-018-0227-y","volume":"37","author":"MC White","year":"2018","unstructured":"White MC, Schroeder RD, Zhu K, Xiong K, McConkey DJ. HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells. Oncogene. 2018;37:4413\u201327.","journal-title":"Oncogene"},{"key":"7586_CR18","doi-asserted-by":"crossref","first-page":"58876","DOI":"10.18632\/oncotarget.11417","volume":"7","author":"E Ramos-Fernandez","year":"2016","unstructured":"Ramos-Fernandez E, Tajes M, Ill-Raga G, Vargas L, Busquets-Garcia A, Bosch-Morato M, et al. Glutamatergic stimulation induces GluN2B translation by the nitric oxide-Heme-Regulated eIF2alpha kinase in cortical neurons. Oncotarget. 2016;7:58876\u201392.","journal-title":"Oncotarget"},{"key":"7586_CR19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/ars.2014.6080","volume":"22","author":"G Ill-Raga","year":"2015","unstructured":"Ill-Raga G, Tajes M, Busquets-Garcia A, Ramos-Fernandez E, Vargas LM, Bosch-Morato M, et al. Physiological control of nitric oxide in neuronal BACE1 translation by Heme-regulated eIF2alpha Kinase HRI induces Synaptogenesis. Antioxid Redox Signal. 2015;22:1295\u2013307.","journal-title":"Antioxid Redox Signal"},{"key":"7586_CR20","doi-asserted-by":"crossref","first-page":"33324","DOI":"10.1074\/jbc.M110.140699","volume":"285","author":"CL Frank","year":"2010","unstructured":"Frank CL, Ge X, Xie Z, Zhou Y, Tsai LH. Control of activating transcription factor 4 (ATF4) persistence by multisite phosphorylation impacts cell cycle progression and neurogenesis. J Biol Chem. 2010;285:33324\u201337.","journal-title":"J Biol Chem"},{"key":"7586_CR21","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/cdd.2012.77","volume":"19","author":"S Kondo","year":"2012","unstructured":"Kondo S, Hino SI, Saito A, Kanemoto S, Kawasaki N, Asada R, et al. Activation of OASIS family, ER stress transducers, is dependent on its stabilization. Cell Death Differ. 2012;19:1939\u201349.","journal-title":"Cell Death Differ"},{"key":"7586_CR22","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","volume":"278","author":"WB Stine Jr","year":"2003","unstructured":"Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem. 2003;278:11612\u201322.","journal-title":"J Biol Chem"},{"key":"7586_CR23","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.","journal-title":"Genome Biol"},{"key":"7586_CR24","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","volume":"6","author":"HP Harding","year":"2000","unstructured":"Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell. 2000;6:1099\u2013108.","journal-title":"Mol Cell"},{"key":"7586_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/iub.433","volume":"63","author":"S Kondo","year":"2011","unstructured":"Kondo S, Saito A, Asada R, Kanemoto S, Imaizumi K. Physiological unfolded protein response regulated by OASIS family members, transmembrane bZIP transcription factors. IUBMB Life. 2011;63:233\u20139.","journal-title":"IUBMB Life"},{"key":"7586_CR26","doi-asserted-by":"crossref","unstructured":"Axten JM, Medina JR, Feng Y, Shu A, Romeril SP, Grant SW, et al. Discovery of 7-methyl-5-(1-[3-(trifluoromethyl)phenyl]acetyl-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J Med Chem. 2012;55:7193\u2013207.","DOI":"10.1021\/jm300713s"},{"key":"7586_CR27","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1074\/jbc.M413660200","volume":"280","author":"HY Jiang","year":"2005","unstructured":"Jiang HY, Wek RC. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem. 2005;280:14189\u2013202.","journal-title":"J Biol Chem"},{"key":"7586_CR28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","volume":"75","author":"JN Keller","year":"2000","unstructured":"Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer\u2019s disease. J Neurochem. 2000;75:436\u20139.","journal-title":"J Neurochem"},{"key":"7586_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03509-0","volume":"9","author":"TA Thibaudeau","year":"2018","unstructured":"Thibaudeau TA, Anderson RT, Smith DM. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat Commun. 2018;9:1097.","journal-title":"Nat Commun"},{"key":"7586_CR30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","volume":"85","author":"S Keck","year":"2003","unstructured":"Keck S, Nitsch R, Grune T, Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer\u2019s disease. J Neurochem. 2003;85:115\u201322.","journal-title":"J Neurochem"},{"key":"7586_CR31","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","volume":"26","author":"CG Almeida","year":"2006","unstructured":"Almeida CG, Takahashi RH, Gouras GK. Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci. 2006;26:4277\u201388.","journal-title":"J Neurosci"},{"key":"7586_CR32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","volume":"29","author":"BP Tseng","year":"2008","unstructured":"Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging. 2008;29:1607\u201318.","journal-title":"Neurobiol Aging"},{"key":"7586_CR33","volume":"13","author":"CW Park","year":"2020","unstructured":"Park CW, Jung BK, Ryu KY. Reduced free ubiquitin levels and proteasome activity in cultured neurons and brain tissues treated with amyloid beta aggregates. Mol Brain. 2020;13:89.","journal-title":"Mol Brain"},{"key":"7586_CR34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.mad.2005.07.006","volume":"126","author":"S Oh","year":"2005","unstructured":"Oh S, Hong HS, Hwang E, Sim HJ, Lee W, Shin SJ, et al. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech Ageing Dev. 2005;126:1292\u20139.","journal-title":"Mech Ageing Dev"},{"key":"7586_CR35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/cn100067e","volume":"1","author":"X Zhao","year":"2010","unstructured":"Zhao X, Yang J. Amyloid-beta peptide is a substrate of the human 20S proteasome. ACS Chem Neurosci. 2010;1:655\u201360.","journal-title":"ACS Chem Neurosci"},{"key":"7586_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-4886(02)00060-2","volume":"180","author":"M Lopez Salon","year":"2003","unstructured":"Lopez Salon M, Pasquini L, Besio Moreno M, Pasquini JM, Soto E. Relationship between beta-amyloid degradation and the 26S proteasome in neural cells. Exp Neurol. 2003;180:131\u201343.","journal-title":"Exp Neurol"},{"key":"7586_CR37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.celrep.2019.08.101","volume":"29","author":"EP McCurdy","year":"2019","unstructured":"McCurdy EP, Chung KM, Benitez-Agosto CR, Hengst U. Promotion of Axon growth by the secreted end of a transcription factor. Cell Rep. 2019;29:363\u2013377.e365.","journal-title":"Cell Rep."},{"key":"7586_CR38","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/j.1742-4658.2012.08619.x","volume":"279","author":"M Guan","year":"2012","unstructured":"Guan M, Fousek K, Chow WA. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer. FEBS J. 2012;279:2399\u2013411.","journal-title":"FEBS J"},{"key":"7586_CR39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw4144","volume":"365","author":"M Abdel-Nour","year":"2019","unstructured":"Abdel-Nour M, Carneiro LAM, Downey J, Tsalikis J, Outlioua A, Prescott D, et al. The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling. Science. 2019;365:eaaw4144.","journal-title":"Science"},{"key":"7586_CR40","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014415","volume":"296","author":"T Mukherjee","year":"2021","unstructured":"Mukherjee T, Ramaglia V, Abdel-Nour M, Bianchi AA, Tsalikis J, Chau HN, et al. The eIF2alpha kinase HRI triggers the autophagic clearance of cytosolic protein aggregates. J Biol Chem. 2021;296.100050.","journal-title":"J Biol Chem"},{"key":"7586_CR41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nchembio.613","volume":"7","author":"T Chen","year":"2011","unstructured":"Chen T, Ozel D, Qiao Y, Harbinski F, Chen L, Denoyelle S, et al. Chemical genetics identify eIF2alpha kinase heme-regulated inhibitor as an anticancer target. Nat Chem Biol. 2011;7:610\u20136.","journal-title":"Nat Chem Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07586-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:55:22Z","timestamp":1743450922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7586"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07586-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The use of animals for this study was evaluated and approved by the Institutional Animal Care and Use Committee (IACUC) of Columbia University (protocol AC-AABO8554).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"225"}}